GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines
By Blake Brittain (Reuters) -British drugmaker GlaxoSmithKline sued Moderna in U.S. federal court in Delaware on Tuesday, accusing its American rival of violating GSK’s patent